Showing 881-890 of 2993 results for "".
Headache Medicine Update: What’s New in CGRP Functional Blocking Agents
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-medicine-update-whats-new-in-cgrp-functional-blocking-agents/32126/CGRP blocking agents have demonstrated success in migraine treatment and can be used in various settings, in different combinations, and for different headache conditions.Practical Recommendations for Monitoring Response to Amyloid-Targeting Treatments for Early Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/practical-recommendations-for-monitoring-response-to-amyloid-targeting-treatments-for-early-alzheimer-disease/36189/The authors present practical recommendations for using cognitive assessments and amyloid PET scanning to monitor response to amyloid-targeting treatments in clinical practice.Blood Pressure Targets After Stroke: How Low Is Too Low?
https://practicalneurology.com/diseases-diagnoses/stroke/blood-pressure-targets-after-stroke-how-low-is-too-low/49161/Acute hypertensive response management after stroke is a dynamic process that requires careful integration of clinical trial evidence, pathophysiologic principles, imaging findings, and patient-specific factors.Neuromuscular Notes: A Practical Approach to the Diagnosis and Management of Muscle Cramps
https://practicalneurology.com/diseases-diagnoses/neuromuscular/a-practical-approach-to-the-diagnosis-and-management-of-muscle-cramps/36116/Frequent or severe muscle cramps can cause prolonged postcramp soreness and diminish quality of life by disrupting sleep, limiting physical activity, and provoking anxiety about symptom recurrence.A Practical Approach to Selecting Patients for Amyloid-Targeting Treatments
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/a-practical-approach-to-selecting-patients-for-amyloid-targeting-treatments/36190/A review of the clinical criteria, key challenges, and future directions in selecting patients for amyloid-targeting treatments.Are Anti-amyloid Therapies Still Worth Being Developed as Treatments for Alzheimer's Disease?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/are-anti-amyloid-therapies-still-worth-being-developed-as-treatments-for-alzheimers-disease/30832/Despite limited pharmaceutical success thus far, amyloid peptides may yet prove useful in the treatment of Alzheimer's and delay disease progression.Sleep Bulletin: Diagnosis and Treatment Options for Narcolepsy and Idiopathic Hypersomnia
https://practicalneurology.com/diseases-diagnoses/sleep/sleep-bulletin-diagnosis-and-treatment-options-for-narcolepsy-and-idiopathic-hypersomnia/32020/Clinical guidance about distinguishing between two sleep disorders with overlapping symptoms.Illicit Neurology: Taking Issue When the Other Illicit Shoe Drops
https://practicalneurology.com/diseases-diagnoses/headache-pain/illicit-neurology-taking-issue-when-the-other-illicit-shoe-drops/31950/There's growing evidence that scheduled drugs can be effective for the treatment of various neurological and psychiatric disorders.Disclosing Risk Factors to Individuals Without Cognitive Impairment
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/disclosing-risk-factors-to-individuals-withoutcognitive-impairment/31535/Negative consequences of risk factor disclosure are likely to be most severe among people who are inadequately prepared to receive the information.Stiff-Person Syndrome
https://practicalneurology.com/diseases-diagnoses/movement-disorders/stiff-person-syndrome/31707/Treatment consists of immunomodulatory therapies and symptom management.